Rabbit Anti-Human Q86SZ3 Polyclonal Antibody, Unconjugated from Atlas Antibodies

...he family of calcium binding proteins such as calm...pha and beta chain whereas S100B is composed of tw...the antigen presenting cells such as the Langerhan...s in the paracortex of lymph nodes. Epitope: Not...

Cytosol / Particulate Rapid Separation Kit from MBL International

EIA Well-Cover Sheets from Cayman Chemical

Rabbit Anti-Human CLAN Polyclonal Antibody, Unconjugated from IMGENEX

Biology Products:

Rabbit Anti-Human S100 A6 Ab-9 Polyclonal Antibody, Unconjugated from Lab Vision Cytosol / Particulate Rapid Separation Kit from MBL International EIA Well-Cover Sheets from Cayman Chemical Rabbit Anti-Human CLAN Polyclonal Antibody, Unconjugated from IMGENEX

(Date:11/4/2009)...n has received more than $10 million in research g...deral stimulus program, bringing thetotal amount o...23 million. Thirty-three projects achieved stimul... weather. , "The university has thoughtfully und...scholarly excellence to federal agency priorities....

(Date:11/4/2009)...wire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE ), a...etrics software, today reported financial results ... ,, Michael Tzannes, Aware,s Chairman and Chief...nced an agreement to sell our DSL and home network...ductor company being spun out of Infineon. This t...

(Date:11/4/2009)...-- Global Rainmakers, Inc., an intellectual proper..., today announced that the company has exited its ...ialize its suite of technologies designed to lever..., During the past four years, the company has spe...oy a series of core--but expandable--technologies ...

Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2 OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3 Aware, Inc. Reports Third Quarter 2009 Financial Results 2 Aware, Inc. Reports Third Quarter 2009 Financial Results 3 Aware, Inc. Reports Third Quarter 2009 Financial Results 4 Aware, Inc. Reports Third Quarter 2009 Financial Results 5 Aware, Inc. Reports Third Quarter 2009 Financial Results 6 Aware, Inc. Reports Third Quarter 2009 Financial Results 7 Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2 Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3 Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 1 Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 2 Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 3 Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 4 Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 5 GSK Improving Performance to Continue in Second Half 52381 1 Red Mango Introduces the First Probiotic Iced Tea July 27 52379 1 Red Mango Introduces the First Probiotic Iced Tea July 27 52379 2 Red Mango Introduces the First Probiotic Iced Tea July 27 52379 3 Red Mango Introduces the First Probiotic Iced Tea July 27 52379 4

[0] OU achieves $10 million in stimulus grants for 33 projects on the Norman campus [0] Aware, Inc. Reports Third Quarter 2009 Financial Results [0] Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality

...the results may not rival the artistry of glassblo...he National Institute of Standards and Technology ... a new fabrication technique called "nanoglassblow... fluidic devices used to isolate and study single ...nds. The novel method is described in a paper post...

...teins upon which life depends share an attribute w...just won,t fly. , But researchers have been puzzl... the ribosome factories in a cell are folded into ...ion. They only have known that for many of the mos...s place out of sight, hidden in the inner cavity o...

...RGHUniversity of Pittsburgh-led researchers discov... can grow on surfaces and that drug-tolerant strai...search team recently reported in Molecular Microb...y human tuberculosis (TB) requires months of inten... cause of the relapses that can nonetheless occur....

Other Biology News:'Nanoglassblowing' seen as boon to study of individual molecules 2 Researchers reveal insights into hidden world of protein folding 2 Researchers reveal insights into hidden world of protein folding 3 Researchers reveal insights into hidden world of protein folding 4 Source of drug-tolerant tuberculosis possibly behind TB relapses, intensity of treatment 2

'Nanoglassblowing' seen as boon to study of individual molecules Researchers reveal insights into hidden world of protein folding Source of drug-tolerant tuberculosis possibly behind TB relapses, intensity of treatment

(Date:11/6/2009)...YWARD, Calif., Nov. 6 Intarcia The...on its ITCA 650 (DUROS® continuous delivery o...iabetes at the Ninth Annual Diabetes Technology Me...ww.newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO )...tide Via ITCA 650 Lowers Plasma Glucose, HbA1c and...

(Date:11/5/2009)...LLINGTON, Colo., Nov. 5 The endang...s in the western U.S. This rare carnivore feeds o...tible to plague and often entire population die-of...ervice (FWS) has implemented a ferret breeding pro...ts into their formerly native habitat. Unfortunat...

(Date:11/5/2009)...nference Call on Thursday, November 5, 2009 at 4:3...ER Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pharm...ASDAQ: OGXI ) today reported unaudited financial ...d September 30, 2009 and reviewed the Company,s hi...following consolidated results reflect the operati...

(Date:11/5/2009)...RT WORTH, Texas, Nov. 5 ...nced today that it has entered into a Letter of In...Virtual Health Technologies, Inc. (OTC Bulletin Bo...$1,000,000 in cash and debt, 4,000,000 shares of W... by WNDM on the Veriscrip technology being acquire...

Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2 Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3 Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4 Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5 Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2 OncoGenex Reports Third Quarter 2009 Financial Results 2 OncoGenex Reports Third Quarter 2009 Financial Results 3 OncoGenex Reports Third Quarter 2009 Financial Results 4 OncoGenex Reports Third Quarter 2009 Financial Results 5 OncoGenex Reports Third Quarter 2009 Financial Results 6 OncoGenex Reports Third Quarter 2009 Financial Results 7 OncoGenex Reports Third Quarter 2009 Financial Results 8 OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2 OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3

[0] Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting [0] Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret [0] OncoGenex Reports Third Quarter 2009 Financial Results [0] OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock

Products	Rabbit Anti-Human Q86SZ3 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Company	Atlas Antibodies
Item	Rabbit Anti-Human Q86SZ3 Polyclonal Antibody, Unconjugated
Price	$350.00
Description	Full-length cDNA clone CS0DJ013YG01 of T cells (Jurkat cell line) of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86SZ3] Antigen: Recombinant Protein Epitope Signature Tag (PrEST).
Info	Atlas Antibodies AlbaNova University Center SE-106 91 Stockholm, Sweden Customer Service: +46 8 54 59 58 50 Fax Number: +46 8 54 59 58 51 Web Site: http://www.atlasantibodies.com